| answer text |
<p>The UK is committed to rapid equitable access to safe and effective vaccines, and
has committed £548 million to the COVAX Advance Market Commitment (AMC), which is
the international initiative to support global equitable access to vaccines, of which
the UK is one of the largest bilateral donors. Our commitment has helped encourage
other donors to commit $1 billion by the end of 2020, and will contribute to the supply
of at least 1.3 billion doses of COVID-19 vaccines in 2021 for up to 92 developing
countries. Over 100 countries and territories have received COVAX deliveries. The
Prime Minister has also said that the UK will share the majority of future vaccine
doses surplus to domestic needs with COVAX.</p><p>The COVAX AMC aims to supply fully
subsidised doses sufficient to vaccinate up to 20 per cent of country populations,
initially prioritising healthcare workers, and then expanding to cover other priority
groups. Countries will then be able to procure additional subsidised doses, subject
to vaccine availability, to increase coverage further. COVAX is supporting countries
to assess vaccine introduction readiness, and to develop detailed national deployment
and vaccination plans, including support needed to strengthen delivery systems. Our
network of health advisers in AMC countries are working to support host governments
to apply to the COVAX AMC and prepare for vaccine delivery.</p>
|
|
